Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Radius Health, Inc.

NASDAQ

Market Cap.

494.81M

Avg. Volume

217.08K

AI Analyst

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Radius Health, Inc.!

Still processing it, give me a bit more time...

Radius Health, Inc. News

Radius Health, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

HealthcareDrug Manufacturers - Specialty & Generic
radiuspharm.com

About Radius Health, Inc.

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.

Radius Health, Inc. Earnings & Revenue

Radius Health, Inc. Financials

Table Compare

Compare RDUS metrics with:

   

Earnings & Growth

RDUS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RDUS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RDUS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RDUS

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Radius Health, Inc. Income

Radius Health, Inc. Balance Sheet

Radius Health, Inc. Cash Flow

Radius Health, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Radius Health, Inc. Dividends

Payment DateDividendFrequency
2024-05-060.1875Quarterly
2024-02-200.1875Quarterly
2023-11-270.1875Quarterly
2023-07-310.1875Quarterly
2023-05-080.1875Quarterly

Historical Market Cap

Shares Outstanding

Radius Health, Inc. Insider Trades

Date8 Apr
NameKelley Erika K.
Role
TransactionDisposed
Type
Shares0
Date20 Feb
NameMINOR GLENDA J
RoleDirector
TransactionAcquired
TypeA-Award
Shares94.904
Date20 Feb
NameSUTHERLIN MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares406.057
Date20 Feb
NameSHOEMAKER LESLIE L
RoleDirector
TransactionAcquired
TypeA-Award
Shares43.262
Date20 Feb
NameJahnke David L
RoleDirector
TransactionAcquired
TypeA-Award
Shares514.778
DateNameRoleTransactionTypeShares
8 AprKelley Erika K.Disposed0
20 FebMINOR GLENDA JDirectorAcquiredA-Award94.904
20 FebSUTHERLIN MICHAEL WDirectorAcquiredA-Award406.057
20 FebSHOEMAKER LESLIE LDirectorAcquiredA-Award43.262
20 FebJahnke David LDirectorAcquiredA-Award514.778

Discover More

Radius Health, Inc.

NASDAQ

Market Cap.

494.81M

Avg. Volume

217.08K

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Radius Health, Inc. News

Radius Health, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Radius Health, Inc. Earnings & Revenue

Radius Health, Inc. Income

Radius Health, Inc. Balance Sheet

Radius Health, Inc. Cash Flow

Radius Health, Inc. Financials Over Time

Radius Health, Inc. Executives

No data available

NameRoleGenderDate of BirthPay

No data available

Radius Health, Inc. Insider Trades

Date8 Apr
NameKelley Erika K.
Role
TransactionDisposed
Type
Shares0
Date20 Feb
NameMINOR GLENDA J
RoleDirector
TransactionAcquired
TypeA-Award
Shares94.904
Date20 Feb
NameSUTHERLIN MICHAEL W
RoleDirector
TransactionAcquired
TypeA-Award
Shares406.057
Date20 Feb
NameSHOEMAKER LESLIE L
RoleDirector
TransactionAcquired
TypeA-Award
Shares43.262
Date20 Feb
NameJahnke David L
RoleDirector
TransactionAcquired
TypeA-Award
Shares514.778
DateNameRoleTransactionTypeShares
8 AprKelley Erika K.Disposed0
20 FebMINOR GLENDA JDirectorAcquiredA-Award94.904
20 FebSUTHERLIN MICHAEL WDirectorAcquiredA-Award406.057
20 FebSHOEMAKER LESLIE LDirectorAcquiredA-Award43.262
20 FebJahnke David LDirectorAcquiredA-Award514.778
HealthcareDrug Manufacturers - Specialty & Generic
radiuspharm.com

About Radius Health, Inc.

Radius Health, Inc., a biopharmaceutical company, focuses on addressing unmet medical needs in the areas of bone health, orphan diseases, and oncology. The company's commercial product is TYMLOS, an abaloparatide injection for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in Phase III clinical trials for the treatment of osteoporosis in men; abaloparatide-TD, a transdermal system that is in Phase III clinical trials to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in Phase III clinical trials for the treatment of hormone-receptor positive breast cancer; and RAD011, which is in Phase II clinical trials for treatment of hyperphagia related to Prader-Willi syndrome. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Teijin Limited; Berlin-Chemie AG; Eisai Co. Ltd.; and Duke University. Radius Health, Inc. was founded in 2003 and is headquartered in Boston, Massachusetts. As of August 10, 2022, Radius Health, Inc. was taken private.

AI Analyst

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Radius Health, Inc.!

Still processing it, give me a bit more time...

Radius Health, Inc. Financials

Table Compare

Compare RDUS metrics with:

   

Earnings & Growth

RDUS

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

RDUS

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

RDUS

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

RDUS

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Radius Health, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityNeutral
Return on AssetsBuy
Debt/Equity RatioStrong Buy
Price/Earnings RatioBuy
Price/Book RatioNeutral

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Radius Health, Inc. Dividends

Payment DateDividendFrequency
2024-05-060.1875Quarterly
2024-02-200.1875Quarterly
2023-11-270.1875Quarterly
2023-07-310.1875Quarterly
2023-05-080.1875Quarterly

Historical Market Cap

Shares Outstanding

Discover More